NASDAQ:BOLT

Bolt Biotherapeutics . Stock Forecast

etoro logo Buy BOLT
*Your capital is at risk
$4.43
-0.190 (-4.11%)
At Close: Jun 10, 2026
AI Analysis AI Analysis of BOLT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BOLT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Bolt Biotherapeutics, Inc. stock price ended at $4.43 on Wednesday, after losing 4.11%
(Updated on Jun 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 03, 2026 Loss -4.32%

The Bolt Biotherapeutics, Inc. stock price fell by -4.11% on the last day (Wednesday, 10th Jun 2026) from $4.62 to $4.43. During the last trading day the stock fluctuated 6.19% from a day low at $4.43 to a day high of $4.70. The price has fallen in 6 of the last 10 days and is down by -16.18% for this period. Volume has increased on the last day by 6 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 11 thousand shares were bought and sold for approximately $49.13 thousand.

The stock has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $4.50. A reaction back to this level may hold a second chance to get out before further falls.

BOLT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bolt Biotherapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.69 and $4.84. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -16.57%. Further fall is indicated until a new bottom pivot has been found. Bolt Biotherapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Bolt Biotherapeutics, Inc. stock

Bolt Biotherapeutics, Inc. finds support from accumulated volume at $4.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.274 between high and low, or 6.19%. For the last week, the stock has had daily average volatility of 5.47%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BOLT) For The Upcoming Trading Day Of Thursday 11th

For the upcoming trading day on Thursday, 11th we expect Bolt Biotherapeutics, Inc. to open at $4.52, and during the day (based on 14 day Average True Range), to move between $4.25 and $4.61, which gives a possible trading interval of +/-$0.350 (+/-8.23%) up or down from last closing price. If Bolt Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.36 (1.58%) than the resistance at $4.61 (4.06%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bolt Biotherapeutics, Inc. stock A Buy?

The Bolt Biotherapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Bolt Biotherapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.191 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 11, 2026 - $4.52 ( 2.06%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BOLT Performance

Trading levels for BOLT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.80 8.25%
R2 4.69 5.88%
R1 4.63 4.42%
Price 4.43
S1 4.42 -0.301%
S2 4.35 -1.76%
S3 4.25 -4.12%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.39 21.67%
R2 4.96 11.96%
R1 4.61 4.06%
Price 4.43
S1 4.36 -1.58%
S2 4.29 -3.16%
S3 3.91 -11.74%

BOLT Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Aug 13, 2014 Aug 29, 2014 Oct 02, 2014 $0.0900 0%
2 Apr 24, 2014 Jun 10, 2014 Jul 09, 2014 $0.0900 0%
3 Jan 22, 2014 Mar 03, 2014 Apr 02, 2014 $0.0900 0%
4 Nov 27, 2013 Dec 30, 2013 Jan 15, 2014 $0.0900 0%
5 Aug 14, 2013 Sep 03, 2013 Oct 03, 2013 $0.0900 0%

FAQ

What is the symbol for Bolt Biotherapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Bolt Biotherapeutics, Inc. is BOLT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bolt Biotherapeutics, Inc. Stock?
The Bolt Biotherapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Bolt Biotherapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Bolt Biotherapeutics, Inc. Stock?
Bolt Biotherapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bolt Biotherapeutics, Inc. Stock.

What's the current price of Bolt Biotherapeutics, Inc. Stock?
As of the end of day on the Jun 10, 2026, the price of an Bolt Biotherapeutics, Inc. (BOLT) share was $4.43.

What is the 52-week high and low for Bolt Biotherapeutics, Inc. Stock?
The 52-week high for Bolt Biotherapeutics, Inc. Stock is $7.35 and the 52-week low is $3.91.

What is the market capitalization of Bolt Biotherapeutics, Inc. Stock?
As of the Jun 10, 2026, the market capitalization of Bolt Biotherapeutics, Inc. is 8.513M.

When is the next earnings date for Bolt Biotherapeutics, Inc. ?
The upcoming earnings date for Bolt Biotherapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT BOLT BIOTHERAPEUTICS, INC.
Bolt Biotherapeutics .
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for col...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
4.95% Jun 05
TPR
$140.47
0.320% Jun 04
N
NVRI
$19.53
4.92% May 20
GLBE
$31.61
3.54% May 05
FIZZ
$34.11
8.80% May 01

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE